In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...

"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as ...

A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

A SPECIFIC microbial ratio in the gut microbiome, characterised by a lower Bifidobacterium to Akkermansia ratio, has been ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

Among patients with multiple sclerosis, depression or anxiety are associated with being on Medicaid, clinical relapse, and DMT delay.

Tolebrutinib is more effective in reducing the risk of disability progression in MS patients with paramagnetic rim lesions, ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...